001     60109
005     20200402205527.0
024 7 _ |2 pmid
|a pmid:17963690
024 7 _ |2 DOI
|a 10.1016/j.bbrc.2007.10.085
024 7 _ |2 WOS
|a WOS:000251358500031
024 7 _ |a altmetric:21818208
|2 altmetric
037 _ _ |a PreJuSER-60109
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
084 _ _ |2 WoS
|a Biophysics
100 1 _ |a Funke, S. A.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB65869
245 _ _ |a Single particle detection of amyloid-ß aggregates associated with Alzheimer's disease
260 _ _ |a Orlando, Fla.
|b Academic Press
|c 2007
300 _ _ |a 902 - 907
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Biochemical and Biophysical Research Communications
|x 0006-291X
|0 787
|v 364
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia. Today, AD can be diagnosed with certainty only post-mortem, by histopathologic staining of Abeta plaques and neurofibrillary tangles in brain tissue sections. We have developed an ultra-sensitive assay potentially suitable for early and non-invasive diagnosis of AD. This highly specific and sensitive assay uses fluorescence correlation spectroscopy (FCS) and is sensitive enough to detect even single aggregates in body fluids of AD patients. First results show a clear distinction between AD diseased people and non-demented controls by analysing cerebrospinal fluids (CSF) by confocal scanning of surface captured Abeta aggregates and subsequent two-dimensional fluorescence intensity distribution analysis.
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Alzheimer Disease: cerebrospinal fluid
650 _ 2 |2 MeSH
|a Alzheimer Disease: diagnosis
650 _ 2 |2 MeSH
|a Amyloid beta-Peptides: analysis
650 _ 2 |2 MeSH
|a Amyloid beta-Peptides: ultrastructure
650 _ 2 |2 MeSH
|a Cerebrospinal Fluid: cytology
650 _ 2 |2 MeSH
|a Cerebrospinal Fluid: metabolism
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Image Enhancement: methods
650 _ 2 |2 MeSH
|a Microscopy, Confocal: methods
650 _ 2 |2 MeSH
|a Microscopy, Fluorescence: methods
650 _ 2 |2 MeSH
|a Particle Size
650 _ 7 |0 0
|2 NLM Chemicals
|a Amyloid beta-Peptides
650 _ 7 |a J
|2 WoSType
653 2 0 |2 Author
|a Alzheimer's disease
653 2 0 |2 Author
|a early diagnosis
653 2 0 |2 Author
|a amyloid-beta aggregates
653 2 0 |2 Author
|a fluorescence correlation spectroscopy (FCS)
653 2 0 |2 Author
|a protein misfolding diseases
700 1 _ |a Birkmann, E.
|b 1
|u FZJ
|0 P:(DE-Juel1)VDB65870
700 1 _ |a Henke, F.
|b 2
|u FZJ
|0 P:(DE-Juel1)VDB65871
700 1 _ |a Görtz, P.
|b 3
|u FZJ
|0 P:(DE-Juel1)VDB72722
700 1 _ |a Lange-Asschenfeldt, C.
|b 4
|u FZJ
|0 P:(DE-Juel1)VDB72723
700 1 _ |a Riesner, D.
|b 5
|u FZJ
|0 P:(DE-Juel1)VDB2263
700 1 _ |a Willbold, D.
|b 6
|u FZJ
|0 P:(DE-Juel1)132029
773 _ _ |a 10.1016/j.bbrc.2007.10.085
|g Vol. 364, p. 902 - 907
|p 902 - 907
|q 364<902 - 907
|0 PERI:(DE-600)1461396-7
|t Biochemical and biophysical research communications
|v 364
|y 2007
|x 0006-291X
856 7 _ |u http://dx.doi.org/10.1016/j.bbrc.2007.10.085
909 C O |o oai:juser.fz-juelich.de:60109
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
914 1 _ |y 2007
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k INB-2
|l Molekulare Biophysik
|d 31.12.2008
|g INB
|0 I:(DE-Juel1)VDB805
|x 0
970 _ _ |a VDB:(DE-Juel1)94305
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ISB-2-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ISB-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21